Skip to main content

Table 1 Frequency of anti-HEV IgG EIA reactivity associated with gender and age among participants in the Korea National Health and Nutrition Examination Survey, 2007–2009

From: Hepatitis E Virus (HEV) Seroprevalence in the general population of the Republic of Korea in 2007–2009: a nationwide cross-sectional study

Variable

Tested (n = 2,450)

Positive for anti-HEV, N (%)

Pvalue*

OR (95% CI)

Overall prevalence

2,450

144 (5.9)

-

 

Sex

    

Male

994

77 (7.8)

0.001

1.0

Female

1,456

67 (4.6)

 

0.6 (0.4-0.8)

Age (years)

    

10–19

546

1 (0.2)

<.0001

1.0

20–29

521

6 (1.2)

 

6.3 (0.8-52.9)

30–39

553

13 (2.4)

 

13.1 (1.7-100.6)

40–49

557

67 (12.0)

 

74.5 (10.3-538.5)

50–55

273

57 (20.9)

 

143.8 (19.8- >999.9)

  1. *If P < 0.05, the differences of seroprevalence among compared groups are statistically significant.